These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians. Lee MC; Lin YF; Hu S; Huang YL; Chang SL; Cheng CY; Chang CS Lasers Med Sci; 2018 Nov; 33(8):1733-1738. PubMed ID: 29732522 [TBL] [Abstract][Full Text] [Related]
23. Combining Low Power Fractional CO Esmat S; Z Elramly A; Shahin D; Hilal RF Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829 [TBL] [Abstract][Full Text] [Related]
24. New Protocol for Long-Term Results With a Multi-Pulse Nd:YAG Laser for Melasma Treatment: A Descriptive Cohort Study. Ocampo JCV; Ocampo SV; Vélez NC; Braun M J Drugs Dermatol; 2021 Feb; 20(2):150-154. PubMed ID: 33538564 [TBL] [Abstract][Full Text] [Related]
25. Split-face comparative study of 1550 nm fractional photothermolysis and trichloroacetic acid 15% chemical peeling for facial melasma in Asian skin. Hong SP; Han SS; Choi SJ; Kim MS; Won CH; Lee MW; Choi JH; Moon KC; Kim YJ; Chang SE J Cosmet Laser Ther; 2012 Apr; 14(2):81-6. PubMed ID: 22372386 [TBL] [Abstract][Full Text] [Related]
26. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective? Gokalp H; Akkaya AD; Oram Y J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828 [TBL] [Abstract][Full Text] [Related]
27. A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm Q-switched Nd:YAG laser toning in the treatment of melasma. Hong JK; Shin SH; Park SJ; Seo SJ; Park KY J Dermatolog Treat; 2022 Aug; 33(5):2547-2553. PubMed ID: 35067157 [TBL] [Abstract][Full Text] [Related]
28. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study. Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866 [TBL] [Abstract][Full Text] [Related]
29. A comparative study of low-fluence 1,064 nm Q-Switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients. Lee DB; Suh HS; Choi YS J Cosmet Laser Ther; 2014 Dec; 16(6):264-70. PubMed ID: 24245978 [TBL] [Abstract][Full Text] [Related]
30. A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma. Kar HK; Gupta L; Chauhan A Indian J Dermatol Venereol Leprol; 2012; 78(2):165-71. PubMed ID: 22421647 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of 755-nm picosecond alexandrite laser with topical tranexamic acid versus laser monotherapy for melasma and facial rejuvenation: a multicenter, randomized, double-blinded, split-face study in Chinese patients. Li Y; Yao C; Zhang H; Li L; Song Y Lasers Med Sci; 2022 Sep; 37(7):2879-2887. PubMed ID: 35501519 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients. Yue B; Yang Q; Xu J; Lu Z Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275 [TBL] [Abstract][Full Text] [Related]
33. A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature. Garg S; Vashisht KR; Makadia S J Cosmet Laser Ther; 2019 Aug; 21(5):297-307. PubMed ID: 31010346 [No Abstract] [Full Text] [Related]
34. Safety and efficacy of a picosecond 755-nm alexandrite laser combined with topical tranexamic acid in the treatment of melasma. Zhou N; Tao J; Yi Z; Wu L; Liu Z; Yang B J Cosmet Dermatol; 2024 Nov; 23(11):3579-3584. PubMed ID: 39234928 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic outcome of melasma treatment by dual-wavelength (511 and 578 nm) laser in patients with skin phototypes III-V. Eimpunth S; Wanitphakdeedecha R; Triwongwaranat D; Varothai S; Manuskiatti W Clin Exp Dermatol; 2014 Apr; 39(3):292-7. PubMed ID: 24635063 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial. Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206 [TBL] [Abstract][Full Text] [Related]
37. Laser toning for melasma: A single-centre experience with 38 970 cases. Tian B J Cosmet Laser Ther; 2017 Jun; 19(3):140-142. PubMed ID: 27911217 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma. Suh KS; Sung JY; Roh HJ; Jeon YS; Kim YC; Kim ST J Dermatolog Treat; 2011 Aug; 22(4):233-8. PubMed ID: 20443754 [TBL] [Abstract][Full Text] [Related]
39. The role of 755-nm alexandrite picosecond laser in melasma management. Pulumati A; Jaalouk D; Algarin YA; Nouri K Arch Dermatol Res; 2023 Dec; 316(1):60. PubMed ID: 38151661 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of 1927 nm fractional Thulium fiber laser for the treatment of melasma: a retrospective study of 100 patients. Kurmuş G; Tatlıparmak A; Aksoy B; Koç E; Aşiran Serdar Z; Ergin C J Cosmet Laser Ther; 2019; 21(7-8):408-411. PubMed ID: 31690148 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]